Reaction
Adnexa Uteri Pain reporting signals
As of the last recalculation, Adnexa Uteri Pain appears in 1,260 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is LEVONORGESTREL (PRR 51.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Levonorgestrel | 423 | 51.7 | 51.8 |
| Leuprolide Acetate | 103 | 23.8 | 23.8 |
| Etonogestrel | 43 | 15.4 | 15.4 |
| Etonogestrel And Ethinyl Estradiol | 20 | 15.1 | 15.1 |
| Copper | 38 | 15.0 | 15.0 |
| Progesterone | 15 | 11.0 | 11.0 |
| Drospirenone And Ethinyl Estradiol | 23 | 8.7 | 8.7 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 6 | 4.2 | 4.2 |